The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-03-26
DOI
10.3389/fphys.2019.00304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Structure–Function Paradigm of Endocrine FGFs in Metabolic Diseases
- (2019) Yongde Luo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients
- (2018) Noriaki Maruyama et al. AMERICAN JOURNAL OF NEPHROLOGY
- Bone and blood interactions in human health and disease
- (2018) Rodrigo J. Valderrábano et al. BONE
- Erythropoiesis, EPO, macrophages, and bone
- (2018) Joshua T. Eggold et al. BONE
- Rare, genetically conditioned forms of rickets: Differential diagnosis and advances in diagnostics and treatment
- (2018) I. Michałus et al. CLINICAL GENETICS
- Fibroblast growth factor 23 and Klotho contribute to airway inflammation
- (2018) Stefanie Krick et al. EUROPEAN RESPIRATORY JOURNAL
- Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
- (2018) Rafiou Agoro et al. FASEB JOURNAL
- Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury
- (2018) Luis Toro et al. KIDNEY INTERNATIONAL
- Bone disease in β thalassemia patients: past, present and future perspectives
- (2018) Vincenzo De Sanctis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
- (2018) Mark R Hanudel et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men
- (2018) Arezoo Daryadel et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Biomolecular regulation, composition and nanoarchitecture of bone mineral
- (2018) Atharva A. Poundarik et al. Scientific Reports
- Genetic Causes of Rickets
- (2018) Sezer Acar et al. Journal of Clinical Research in Pediatric Endocrinology
- Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice
- (2018) Olena Andrukhova et al. Frontiers in Endocrinology
- Organ involvement occurs in all forms of hereditary haemolytic anaemia
- (2018) Stephanie van Straaten et al. BRITISH JOURNAL OF HAEMATOLOGY
- α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling
- (2018) Gaozhi Chen et al. NATURE
- Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
- (2017) Erica L. Clinkenbeard et al. HAEMATOLOGICA
- C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients
- (2017) Michele F. Eisenga et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients
- (2017) Kazuomi Yamashita et al. NEPHROLOGY
- α‑klotho and anemia in patients with chronic kidney disease patients: A new perspective (Review)
- (2017) Yang Xu et al. Experimental and Therapeutic Medicine
- Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow
- (2017) Erica L. Clinkenbeard et al. HAEMATOLOGICA
- Alkaline Phosphatase, an Unconventional Immune Protein
- (2017) Bethany A. Rader Frontiers in Immunology
- FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase
- (2017) Ingo Flamme et al. PLoS One
- Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women
- (2016) Erik A. Imel et al. BONE
- Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition
- (2016) Hiroyuki Yamamoto et al. BONE
- Novel Faces of Fibroblast Growth Factor 23 (FGF23): Iron Deficiency, Inflammation, Insulin Resistance, Left Ventricular Hypertrophy, Proteinuria and Acute Kidney Injury
- (2016) Mehmet Kanbay et al. CALCIFIED TISSUE INTERNATIONAL
- Fibroblast Growth Factor 23 and Risk of CKD Progression in Children
- (2016) A. A. Portale et al. Clinical Journal of the American Society of Nephrology
- Inflammation regulates fibroblast growth factor 23 production
- (2016) Connor Francis et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
- (2016) Alexander Grabner et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Bone Disease in Thalassemia: A Molecular and Clinical Overview
- (2016) Phillip Wong et al. ENDOCRINE REVIEWS
- Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice
- (2016) Susanna Canali et al. ENDOCRINOLOGY
- Intact FGF23 and α-klotho during acute inflammation/sepsis in CKD patients
- (2016) Evangelia Dounousi et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2D in macrophages
- (2016) Xiaobin Han et al. FEBS LETTERS
- Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease
- (2016) Marie Courbebaisse et al. HAEMATOLOGICA
- Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance
- (2016) Bangwei Luo et al. IMMUNITY
- Serum Fibroblast Growth Factor 23 (FGF23) in Patients with Rheumatoid Arthritis
- (2016) Hiroe Sato et al. INTERNAL MEDICINE
- Bone Health in Patients With Hematopoietic Disorders of Bone Marrow Origin: Systematic Review and Meta- Analysis
- (2016) Kieran Steer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells
- (2016) Martina Rauner et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome
- (2016) Mary Scott Ramnitz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Conditional Deletion of MurineFgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia
- (2016) Erica L Clinkenbeard et al. JOURNAL OF BONE AND MINERAL RESEARCH
- FGF23 signaling impairs neutrophil recruitment and host defense during CKD
- (2016) Jan Rossaint et al. JOURNAL OF CLINICAL INVESTIGATION
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
- (2016) Saurav Singh et al. KIDNEY INTERNATIONAL
- Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice
- (2016) Sathish K. Murali et al. PLOS BIOLOGY
- Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease
- (2016) Marie Courbebaisse et al. HAEMATOLOGICA
- Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study
- (2016) Rupal Mehta et al. JAMA Cardiology
- A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
- (2015) Geoffrey A. Block et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Elevated erythropoietin and cytokines levels are related to impaired reticulocyte maturation in thalassemic patients
- (2015) Punnee Butthep et al. BLOOD CELLS MOLECULES AND DISEASES
- Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease
- (2015) Matthew S. Karafin et al. BLOOD CELLS MOLECULES AND DISEASES
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
- (2015) Maria Bożentowicz-Wikarek et al. CLINICAL BIOCHEMISTRY
- Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
- (2015) Michał Holecki et al. CLINICAL ENDOCRINOLOGY
- The Iron age of host-microbe interactions
- (2015) M. P. Soares et al. EMBO REPORTS
- Erythropoietin directly stimulates osteoclast precursors and induces bone loss
- (2015) Sahar Hiram-Bab et al. FASEB JOURNAL
- FGF23 Regulates Bone Mineralization in a 1,25(OH)2D3and Klotho-Independent Manner
- (2015) Sathish Kumar Murali et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Key role of the kidney in the regulation of fibroblast growth factor 23
- (2015) Maria L. Mace et al. KIDNEY INTERNATIONAL
- Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
- (2015) Nobuaki Ito et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance
- (2015) Yuqi Liu et al. Scientific Reports
- Hypophosphatemic Rickets: Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis
- (2015) Bracha K. Goldsweig et al. Current Osteoporosis Reports
- Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults
- (2015) Lynae J. Hanks et al. PLoS One
- Intravascular Hemolysis, Vascular Endothelial Cell Activation and Thrombophilia in Splenectomized Patients with Hemoglobin E/β-Thalassemia Disease
- (2014) Vichai Atichartakarn et al. ACTA HAEMATOLOGICA
- Klotho Deficiency Disrupts Hematopoietic Stem Cell Development and Erythropoiesis
- (2014) Sangeetha Vadakke Madathil et al. AMERICAN JOURNAL OF PATHOLOGY
- Coupling fibroblast growth factor 23 production and cleavage
- (2014) Myles Wolf et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Does Erythropoietin Have a Role in the Treatment of β-Hemoglobinopathies?
- (2014) Eitan Fibach et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Erythropoietin Levels in Patients with Sickle Cell Disease Do Not Correlate with Known Inducers of Erythropoietin
- (2014) E. Dianne Pulte et al. HEMOGLOBIN
- Prevalence of Low Bone Mass and Vitamin D Deficiency in β-Thalassemia Major
- (2014) Ploutarchos Tzoulis et al. HEMOGLOBIN
- FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis
- (2014) Lindsay M. Coe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Role of Erythropoietin and Bone Marrow Concentrate in the Treatment of Osteochondral Defects in Mini-Pigs
- (2014) Marcel Betsch et al. PLoS One
- EPO Promotes Bone Repair through Enhanced Cartilaginous Callus Formation and Angiogenesis
- (2014) Lin Wan et al. PLoS One
- Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis
- (2014) V. S. Tagliabracci et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FGF23 and Phosphate Wasting Disorders
- (2014) Xianglan Huang et al. Bone Research
- Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
- (2013) L. C. Baia et al. Clinical Journal of the American Society of Nephrology
- Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
- (2013) Myles Wolf et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice
- (2013) Erica L Clinkenbeard et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study
- (2013) Merche Prats et al. BMC Nephrology
- Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling
- (2012) C. Besson-Fournier et al. BLOOD
- The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO
- (2012) Erinn B. Rankin et al. CELL
- Effects of erythropoietin on osteoblast proliferation and function
- (2012) Lvhua Guo et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Fibroblast Growth Factor 23 and Inflammation in CKD
- (2012) J. Munoz Mendoza et al. Clinical Journal of the American Society of Nephrology
- Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease
- (2012) L. Darryl Quarles EXPERIMENTAL CELL RESEARCH
- Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
- (2012) Edward R. Smith et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D–induced inhibition of bone mineralization
- (2012) Liesbet Lieben et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation and Function of the FGF23/Klotho Endocrine Pathways
- (2012) Aline Martin et al. PHYSIOLOGICAL REVIEWS
- Low Molecular Weight Iron Dextran Increases Fibroblast Growth Factor-23 Concentration, Together With Parathyroid Hormone Decrease in Hemodialyzed Patients
- (2012) Tomasz Hryszko et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Erythropoietin Modulates the Structure of Bone Morphogenetic Protein 2–Engineered Cranial Bone
- (2012) Hongli Sun et al. TISSUE ENGINEERING PART A
- Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho)
- (2011) Emily G. Farrow et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Hematopoiesis and bone remodeling
- (2011) T. Suda BLOOD
- Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment
- (2011) S. Singbrant et al. BLOOD
- Hepcidin and iron regulation, 10 years later
- (2011) T. Ganz BLOOD
- Erythropoietin stimulates bone formation, cell proliferation, and angiogenesis in a femoral segmental defect model in mice
- (2011) J.H. Holstein et al. BONE
- Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes
- (2011) Sylvia T. Singer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Erythropoiesis versus inflammation in Hereditary Spherocytosis clinical outcome
- (2011) Susana Rocha et al. CLINICAL BIOCHEMISTRY
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
- (2011) Erik A. Imel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Erythropoietin augments bone formation in a rabbit posterolateral spinal fusion model
- (2011) Jan Hendrik Duedal Rölfing et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Hypoxia and Inflammation
- (2011) Holger K. Eltzschig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
- (2011) E. G. Farrow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Spine in β-Thalassemia Syndromes
- (2011) Rachid Haidar et al. SPINE
- Sickle-cell disease
- (2010) David C Rees et al. LANCET
- Erythropoietin Couples Hematopoiesis with Bone Formation
- (2010) Yusuke Shiozawa et al. PLoS One
- Monocyte and Macrophage Biology: An Overview
- (2010) Andrew J. Rees SEMINARS IN NEPHROLOGY
- Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study
- (2009) A. T. Taher et al. BLOOD
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis
- (2009) Clemens Bergwitz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
- (2009) Belinda J. Schouten et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice
- (2009) Alexander Weidemann et al. JOURNAL OF CLINICAL INVESTIGATION
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia
- (2009) B. J Schouten et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
- (2007) L. Silvestri et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search